Literature DB >> 10146916

Survey of wastage from intravenous admixture in US hospitals.

S W Birdwell1, G E Meyer, D J Scheckelhoff, C S Giambrone, S A Iteen.   

Abstract

The purpose of this study was to assess current wastage from intravenous systems designed for intermittent use in US hospitals. Questionnaires were mailed to pharmacy directors at 1393 randomly selected hospitals. Respondents were asked to indicate their overall percentage intravenous wastage rate, intravenous admixture policies and procedures, and wastage rates for currently used intermittent intravenous drug delivery systems. If actual data were not available, respondents were asked to provide estimates based on their perceptions of waste. A total of 237 (17.0%) usable responses were returned. The mean intravenous wastage was 2.85% (+/- 3.40) for respondents who provided actual values and 4.28% (+/- 3.83) for respondents who provided estimated values. Lower mean wastage rates were found for hospitals which: (a) received written notification of discontinued intravenous systems; (b) had an elapsed time of less than or equal to 1 hour from discontinuation of the intravenous system to notification in the pharmacy; (c) actively retrieved discontinued intravenous systems from the nursing unit; and (d) had a daily return of discontinued intravenous systems to the pharmacy. Based on actual values provided by respondents, for 9 intravenous systems the mean wastage rates were lowest for commercially prepared intermittent systems such as frozen piggyback systems {1.5% (+/- 1.4)} and piggyback systems stored at room temperature {3.2% (+/- 5.2)}, and 4.4% (+/- 16.0) for nursing-activated ADD-Vantage systems. We expected that pharmacy managers would monitor waste regularly and be able to provide actual values for wastage rates. However, only 124 (53.3%) of the respondents provided actual data.(ABSTRACT TRUNCATED AT 250 WORDS)

Mesh:

Year:  1993        PMID: 10146916     DOI: 10.2165/00019053-199304040-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  5 in total

1.  Cost of wastage in a hospital intravenous admixture program.

Authors:  D J Salberg; R W Newton; D T Leduc
Journal:  Hosp Formul       Date:  1984-05

2.  Reducing waste of intravenous solutions.

Authors:  L D Diehl; E D Goo; L Sumiye; R Ferrell
Journal:  Am J Hosp Pharm       Date:  1992-01

3.  Waste of i.v. admixtures in the ADD-Vantage system and a traditional minibag system.

Authors:  M Billeter; M M Nowak; R P Rapp; M L Hunt
Journal:  Am J Hosp Pharm       Date:  1990-07

4.  Monitoring waste in an intravenous admixture program.

Authors:  S R Mitchell
Journal:  Am J Hosp Pharm       Date:  1987-01

5.  Research design: sampling techniques.

Authors:  D S Pathak; J M Meinhold; D J Fisher
Journal:  Am J Hosp Pharm       Date:  1980-07
  5 in total
  2 in total

1.  Identifying costs of intravenous solution wastage.

Authors:  K M Uchida; S A Iteen; N T Wong
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

Review 2.  Once-daily aminoglycoside administration in gram-negative sepsis. Economic and practical aspects.

Authors:  S E Parker; P G Davey
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.